While in our study, the activities of pristimerin to reduce the cellular cytoskeleton of vimentin and F-actin, cellular adhesion of integrin β1, as well as cellular invasion of MMP2, exerted the multiple ways of anti-cancer potential. The gene discussed is MMP2; the disease is cancer.